Differential upregulation of host cell protein kinases by the replication of α-, β- and γ-herpesviruses provides a signature of virus-specific signalling

References

1. Whitley R, Baines J. Clinical management of herpes simplex virus infections: past, present, and future. F1000. Research 2018; 7:
   [Google Scholar]
2. Carney WP, Hirsch MS. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis 1981; 144:47–54 [View Article]
   [Google Scholar]
3. Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol 2015; 235:288–297 [View Article]
   [Google Scholar]
4. Jha H, Banerjee S, Robertson E. The role of Gammaherpesviruses in cancer pathogenesis. Pathogens 2016; 5:18 [View Article]
   [Google Scholar]
5. Falcinelli SD, Chertow DS, Kindrachuk J. Integration of global analyses of host molecular responses with clinical data to evaluate pathogenesis and advance therapies for emerging and re-emerging viral infections. ACS Infect Dis 2016; 2:787–799 [View Article]
   [Google Scholar]
6. Oberstein A, Perlman DH, Shenk T, Terry LJ. Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome. Proteomics 2015; 15:2006–2022 [View Article]
   [Google Scholar]
7. Hutterer C, Wandinger SK, Wagner S, Müller R, Stamminger T et al. Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, Abl and AMPK. Antiviral Res 2013; 99:139–148 [View Article]
   [Google Scholar]
8. Feichtinger S, Stamminger T, Müller R, Graf L, Klebl B et al. Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1. J Gen Virol 2011; 92:1519–1531 [View Article]
   [Google Scholar]
9. Graf L, Webel R, Wagner S, Hamilton ST, Rawlinson WD et al. The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins. Viruses 2013; 5:3213–3230 [View Article]
   [Google Scholar]
10. Steingruber M, Socher E, Hutterer C, Webel R, Bergbrede T et al. The interaction between cyclin B1 and cytomegalovirus protein kinase pUL97 is determined by an active kinase domain. Viruses 2015; 7:4582–4601 [View Article]
    [Google Scholar]
11. Graf L, Feichtinger S, Naing Z, Hutterer C, Milbradt J et al. New insight into the phosphorylation-regulated intranuclear localization of human cytomegalovirus pUL69 mediated by cyclin-dependent kinases (CDKs) and viral CDK orthologue pUL97. J Gen Virol 2016; 97:144–151 [View Article]
    [Google Scholar]
12. Steingruber M, Kraut A, Socher E, Sticht H, Reichel A et al. Proteomic interaction patterns between human cyclins, the cyclin-dependent kinase ortholog pUL97 and additional cytomegalovirus proteins. Viruses 2016; 8:219 [View Article]
    [Google Scholar]
13. Steingruber M, Keller L, Socher E, Ferre S, Hesse A-M et al. Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97. J Biol Chem 2019; 294:6188–6203 [View Article]
    [Google Scholar]
14. Hertel L, Chou S, Mocarski ES. Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog 2007; 3:e6 [View Article]
    [Google Scholar]
15. Milbradt J, Hutterer C, Bahsi H, Wagner S, Sonntag E et al. The prolyl isomerase Pin1 promotes the Herpesvirus-Induced phosphorylation-dependent disassembly of the nuclear lamina required for nucleocytoplasmic egress. PLoS Pathog 2016; 12:e1005825 [View Article]
    [Google Scholar]
16. Marschall M, Muller YA, Diewald B, Sticht H, Milbradt J. The human cytomegalovirus nuclear egress complex unites multiple functions: recruitment of effectors, nuclear envelope rearrangement, and docking to nuclear capsids. Rev Med Virol 2017; 27:e1934 [View Article]
    [Google Scholar]
17. Terry LJ, Vastag L, Rabinowitz JD, Shenk T. Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection. Proc Natl Acad Sci USA 2012; 109:3071–3076 [View Article]
    [Google Scholar]
18. Hutterer C, Eickhoff J, Milbradt J, Korn K, Zeitträger I et al. A novel CDK7 inhibitor of the Pyrazolotriazine class exerts broad-spectrum antiviral activity at nanomolar concentrations. Antimicrob Agents Chemother 2015; 59:2062–2071 [View Article]
    [Google Scholar]
19. Scherer M, Schilling EM, Stamminger T. The human CMV IE1 protein: an offender of PML nuclear bodies. Adv Anat Embryol Cell Biol 2017; 223:77–94 [View Article]
    [Google Scholar]
20. Kalejta RF. Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev 2008; 72:249–265 [View Article]
    [Google Scholar]
21. Biolatti M, Dell'Oste V, Pautasso S, von Einem J, Marschall M et al. Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability. J Virol 2016; 90:8238–8250 [View Article]
    [Google Scholar]
22. Kas-Deelen AM, The TH, Blom N, van der Strate BW, De Maar EF et al. Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells mediated by phagocytosis and cell fusion?. Intervirology 2001; 44:8–13 [View Article]
    [Google Scholar]
23. Barabas S, Spindler T, Kiener R, Tonar C, Lugner T et al. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity. BMC Immunol 2017; 18:14 [View Article]
    [Google Scholar]
24. Ruzsics Z, Lemnitzer F, Thirion C. Engineering adenovirus genome by bacterial artificial chromosome (BAC) technology. Methods Mol Biol 2014; 1089:143–158 [View Article]
    [Google Scholar]
25. Kiener R, Fleischmann M, Schwegler C, Ruzsics Z, Thirion C et al. Vaccine vectors based on adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo. Sci Rep 2018; 8:1474 [View Article]
    [Google Scholar]
26. Sonntag E, Hamilton ST, Bahsi H, Wagner S, Jonjic S et al. Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components. J Gen Virol 2016; 97:1676–1685 [View Article]
    [Google Scholar]